HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kashyap, S. Articles by Cusi, K. Search for Related Content PubMed PubMed Citation Articles by Kashyap, S. Articles by Cusi, K. Social Bookmarking                What's this?

A Sustained Increase in Plasma Free Fatty Acids Impairs Insulin Secretion in Nondiabetic Subjects Genetically Predisposed to Develop Type 2 Diabetes

¹ Diabetes Division, Department of Medicine, the University of Texas Health Science Center at San Antonio, San Antonio, Texas
² Audie L. Murphy Veterans Administration Medical Center, San Antonio, Texas

Acute elevations in free fatty acids (FFAs) stimulate insulin secretion, but prolonged lipid exposure impairs ß-cell function in both in vitro studies and in vivo animal studies. In humans data are limited to short-term (48 h) lipid infusion studies and have led to conflicting results. We examined insulin secretion and action during a 4-day lipid infusion in healthy normal glucose tolerant subjects with (FH+ group, n = 13) and without (control subjects, n = 8) a family history of type 2 diabetes. Volunteers were admitted twice to the clinical research center and received, in random order, a lipid or saline infusion. On days 1 and 2, insulin and C-peptide concentration were measured as part of a metabolic profile after standardized mixed meals. Insulin secretion in response to glucose was assessed with a +125 mg/dl hyperglycemic clamp on day 3. On day 4, glucose turnover was measured with a euglycemic insulin clamp with [3-³H]glucose. Day-long plasma FFA concentrations with lipid infusion were increased within the physiological range, to levels seen in type 2 diabetes (500–800 µmol/l). Lipid infusion had strikingly opposite effects on insulin secretion in the two groups. After mixed meals, day-long plasma C-peptide levels increased with lipid infusion in control subjects but decreased in the FH+ group (+28 vs. -30%, respectively, P < 0.01). During the hyperglycemic clamp, lipid infusion enhanced the insulin secretion rate (ISR) in control subjects but decreased it in the FH+ group (first phase: +75 vs. -60%, P < 0.001; second phase: +25 vs. -35%, P < 0.04). When the ISR was adjusted for insulin resistance (ISR_Rd = ISR ÷ [1/R_d], where R_d is the rate of insulin-stimulated glucose disposal), the inadequate ß-cell response in the FH+ group was even more evident. Although ISR_Rd was not different between the two groups before lipid infusion, in the FH+ group, lipid infusion reduced first- and second-phase ISR_Rd to 25 and 42% of that in control subjects, respectively (both P < 0.001 vs. control subjects). Lipid infusion in the FH+ group (but not in control subjects) also caused severe hepatic insulin resistance with an increase in basal endogenous glucose production (EGP), despite an elevation in fasting insulin levels, and impaired suppression of EGP to insulin. In summary, in individuals who are genetically predisposed to type 2 diabetes, a sustained physiological increase in plasma FFA impairs insulin secretion in response to mixed meals and to intravenous glucose, suggesting that in subjects at high risk of developing type 2 diabetes, ß-cell lipotoxicity may play an important role in the progression from normal glucose tolerance to overt hyperglycemia.

CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				A. I. Oprescu, G. Bikopoulos, A. Naassan, E. M. Allister, C. Tang, E. Park, H. Uchino, G. F. Lewis, I. G. Fantus, M. Rozakis-Adcock, et al. Free Fatty Acid Induced Reduction in Glucose-Stimulated Insulin Secretion: Evidence for a Role of Oxidative Stress In Vitro and In Vivo Diabetes, December 1, 2007; 56(12): 2927 - 2937. [Abstract] [Full Text] [PDF]

				H. Alkhateeb, A. Chabowski, J. F. C. Glatz, J. F. P. Luiken, and A. Bonen Two phases of palmitate-induced insulin resistance in skeletal muscle: impaired GLUT4 translocation is followed by a reduced GLUT4 intrinsic activity Am J Physiol Endocrinol Metab, September 1, 2007; 293(3): E783 - E793. [Abstract] [Full Text] [PDF]

				R. Valdez, K. J. Greenlund, M. J. Khoury, and P. W. Yoon Is Family History a Useful Tool for Detecting Children at Risk for Diabetes and Cardiovascular Diseases? A Public Health Perspective Pediatrics, September 1, 2007; 120(SUPPLEMENT_2): S78 - S86. [Abstract] [Full Text] [PDF]

				Y. Zhang, M. Xu, S. Zhang, L. Yan, C. Yang, W. Lu, Y. Li, and H. Cheng The role of G protein-coupled receptor 40 in lipoapoptosis in mouse {beta}-cell line NIT-1 J. Mol. Endocrinol., June 1, 2007; 38(6): 651 - 661. [Abstract] [Full Text] [PDF]

				K. Cusi, S. Kashyap, A. Gastaldelli, M. Bajaj, and E. Cersosimo Effects on insulin secretion and insulin action of a 48-h reduction of plasma free fatty acids with acipimox in nondiabetic subjects genetically predisposed to type 2 diabetes Am J Physiol Endocrinol Metab, June 1, 2007; 292(6): E1775 - E1781. [Abstract] [Full Text] [PDF]

				B. L. Wajchenberg {beta}-Cell Failure in Diabetes and Preservation by Clinical Treatment Endocr. Rev., April 1, 2007; 28(2): 187 - 218. [Abstract] [Full Text] [PDF]

				T. T. Goh, T. M. Mason, N. Gupta, A. So, T. K. T. Lam, L. Lam, G. F. Lewis, A. Mari, and A. Giacca Lipid-induced beta-cell dysfunction in vivo in models of progressive beta-cell failure Am J Physiol Endocrinol Metab, February 1, 2007; 292(2): E549 - E560. [Abstract] [Full Text] [PDF]

				A. M. Chang, M. J. Smith, A. T. Galecki, C. J. Bloem, and J. B. Halter Impaired {beta}-Cell Function in Human Aging: Response to Nicotinic Acid-Induced Insulin Resistance J. Clin. Endocrinol. Metab., September 1, 2006; 91(9): 3303 - 3309. [Abstract] [Full Text] [PDF]

				A. Wiederkehr and C. B. Wollheim Minireview: Implication of Mitochondria in Insulin Secretion and Action Endocrinology, June 1, 2006; 147(6): 2643 - 2649. [Abstract] [Full Text] [PDF]

				M. Cnop, N. Welsh, J.-C. Jonas, A. Jorns, S. Lenzen, and D. L. Eizirik Mechanisms of Pancreatic {beta}-Cell Death in Type 1 and Type 2 Diabetes: Many Differences, Few Similarities Diabetes, December 1, 2005; 54(suppl_2): S97 - S107. [Abstract] [Full Text] [PDF]

				R. Belfort, L. Mandarino, S. Kashyap, K. Wirfel, T. Pratipanawatr, R. Berria, R. A. DeFronzo, and K. Cusi Dose-Response Effect of Elevated Plasma Free Fatty Acid on Insulin Signaling Diabetes, June 1, 2005; 54(6): 1640 - 1648. [Abstract] [Full Text] [PDF]

				R. Weiss, S. Caprio, M. Trombetta, S. E. Taksali, W. V. Tamborlane, and R. Bonadonna {beta}-Cell Function Across the Spectrum of Glucose Tolerance in Obese Youth Diabetes, June 1, 2005; 54(6): 1735 - 1743. [Abstract] [Full Text] [PDF]

				G. Boden and M. Laakso Lipids and Glucose in Type 2 Diabetes: What About the {beta}-Cell and the Mitochondria?: Response to Eldor and Raz Diabetes Care, April 1, 2005; 28(4): 986 - 987. [Full Text] [PDF]

				D. K. Richardson, S. Kashyap, M. Bajaj, K. Cusi, S. J. Mandarino, J. Finlayson, R. A. DeFronzo, C. P. Jenkinson, and L. J. Mandarino Lipid Infusion Decreases the Expression of Nuclear Encoded Mitochondrial Genes and Increases the Expression of Extracellular Matrix Genes in Human Skeletal Muscle J. Biol. Chem., March 18, 2005; 280(11): 10290 - 10297. [Abstract] [Full Text] [PDF]

				B. B. Lowell and G. I. Shulman Mitochondrial Dysfunction and Type 2 Diabetes Science, January 21, 2005; 307(5708): 384 - 387. [Abstract] [Full Text] [PDF]

				S. B Haugaard, O. Andersen, F. Dela, J. J. Holst, H. Storgaard, M. Fenger, J. Iversen, and S. Madsbad Defective glucose and lipid metabolism in human immunodeficiency virus-infected patients with lipodystrophy involve liver, muscle tissue and pancreatic {beta}-cells Eur. J. Endocrinol., January 1, 2005; 152(1): 103 - 112. [Abstract] [Full Text] [PDF]

				H. M. Milne, C. J. Burns, P. E. Squires, N. D. Evans, J. Pickup, P. M. Jones, and S. J. Persaud Uncoupling of Nutrient Metabolism From Insulin Secretion by Overexpression of Cytosolic Phospholipase A2 Diabetes, January 1, 2005; 54(1): 116 - 124. [Abstract] [Full Text] [PDF]

				S. B. Haugaard, O. Andersen, H. Storgaard, F. Dela, J. J. Holst, J. Iversen, J. O. Nielsen, and S. Madsbad Insulin secretion in lipodystrophic HIV-infected patients is associated with high levels of nonglucose secretagogues and insulin resistance of {beta}-cells Am J Physiol Endocrinol Metab, October 1, 2004; 287(4): E677 - E685. [Abstract] [Full Text] [PDF]

				G. Boden and M. Laakso Lipids and Glucose in Type 2 Diabetes: What is the cause and effect? Diabetes Care, September 1, 2004; 27(9): 2253 - 2259. [Full Text] [PDF]

				S. R. Kashyap, R. Belfort, R. Berria, S. Suraamornkul, T. Pratipranawatr, J. Finlayson, A. Barrentine, M. Bajaj, L. Mandarino, R. DeFronzo, et al. Discordant effects of a chronic physiological increase in plasma FFA on insulin signaling in healthy subjects with or without a family history of type 2 diabetes Am J Physiol Endocrinol Metab, September 1, 2004; 287(3): E537 - E546. [Abstract] [Full Text] [PDF]